Items where authors include "Gillatt, D."

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 9.

Article

Lane, J.A., Donovan, J.L., Young, G.J. et al. (26 more authors) (2022) Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study). BJU International, 130 (3). pp. 370-380. ISSN 1464-4096

Wade, J., Donovan, J., Lane, A. et al. (21 more authors) (2020) Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trial. BMJ Open, 10 (9). e036024. ISSN 2044-6055

Hamdy, F.C., Donovan, J.L., Lane, J.A. et al. (33 more authors) (2020) Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer : the ProtecT three-arm RCT. Health Technology Assessment, 24 (37). pp. 1-175. ISSN 1366-5278

Neal, D.E., Metcalfe, C., Donovan, J.L. et al. (26 more authors) (2020) Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the ProtecT randomised controlled trial according to treatment received. European Urology, 77 (3). pp. 320-330. ISSN 0302-2838

Johnston, T.J., Shaw, G.L., Lamb, A.D. et al. (29 more authors) (2017) Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial. European Urology, 71 (3). pp. 381-388. ISSN 0302-2838

Hamdy, F.C., Donovan, J.L., Lane, J.A. et al. (25 more authors) (2016) 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. New England Journal of Medicine. ISSN 0028-4793

Donovan, J.L., Hamdy, F.C., Lane, J.A. et al. (36 more authors) (2016) Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. New England Journal of Medicine. ISSN 0028-4793

Oliver, S.E., Barrass, B., Gunnell, D.J. et al. (7 more authors) (2004) Serum Insulin-Like Growth Factor-I Is Positively Associated With Serum Prostate-Specific Antigen in Middle-Aged Men Without Evidence of Prostate Cancer. Cancer Epidemiology Biomarkers & Prevention, 13 (1). pp. 163-165. ISSN 1055-9965

Oliver, S.E., Gunnell, D., Donovan, J. et al. (7 more authors) (2003) Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control study. International Journal of Cancer, 108 (6). pp. 887-892. ISSN 0020-7136

This list was generated on Sat Mar 23 18:25:22 2024 GMT.